1977
DOI: 10.1007/bf01945954
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against Schistosomes and Cestodes

Abstract: Synthesis and properties of 2-cyclohexylcarbonyl-1,3,4,6,7,11b-hexahydro-2H-pyrazino [2,1-a] isoquinolin-4-one, a novel anthelmintic with excellent activity against all species of Schistosomes pathogenic to man and a wide range of cestodes, will be reported.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
35
0
6

Year Published

1999
1999
2018
2018

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 123 publications
(42 citation statements)
references
References 2 publications
0
35
0
6
Order By: Relevance
“…Praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one) was synthesized in the 1970s (59). While undergoing initial veterinary screening it showed efficacy against cestodes (33,62).…”
Section: Antischistosomal Properties Of Praziquantelmentioning
confidence: 99%
“…Praziquantel (2-cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one) was synthesized in the 1970s (59). While undergoing initial veterinary screening it showed efficacy against cestodes (33,62).…”
Section: Antischistosomal Properties Of Praziquantelmentioning
confidence: 99%
“…Schistosomiasis mostly affects the liver and intestine with granuloma formation; necrosis and fibrosis are more common in hepatic tissues [16]. Praziquantel (PZQ), a drug used for treatment of schistosomiasis, was developed by Seubert et al [52]. Praziquantel and Oxamniquine have been extensively used in the treatment of schistosomiasis with good efficiency and low toxicity [32].…”
Section: Introductionmentioning
confidence: 99%
“…The drug of choice for treating all schistosome species is Praziquantel (PZQ).It was developed in the late 1970s (Seubert et al, 1977) and has become the only available drug used in control programs (Doenhoff et al, 2008).However, this drug is not effective in the treatment of immature forms or preventing re-infection (Magnussen, 2003). Furthermore, the extensive usage of PZQ, in non-infected and non-diagnosed individuals for prevention, lead to emergence of resistant strains of Schistosoma mansoni (Melman et The resistance of PZQ has already been documented in Egypt and Senegal, in conjunction with new findings about its metabolism and genotoxic properties.…”
Section: Introduction:-mentioning
confidence: 99%